All terms in EFO
| Label | Id | Description |
|---|---|---|
| nephrolithiasis | EFO_0004253 | [Formation of stones in the KIDNEY., Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE., The presence of a calculus in the pelvis of the kidney; this is most often composed of mineral salts and proteins.] |
| dense deposit disease | MONDO_0019736 | [Dense deposit disease, a histological subtype of MPGN is an idiopathic chronic progressive kidney disorder distinguished by the presence of intra-membranous dense deposits in addition to immune complex subendothelial deposits in the glomerular capillary walls. This form often has a higher recurrence rate after a kidney transplant and is associated with extra-renal manifestations such as familial drusen.] |
| X-linked sideroblastic anemia 1 | MONDO_0020721 | |
| inborn disorder of porphyrin metabolism | MONDO_0017754 | [An acquired metabolic disease that is has its basis in the disruption of porphyrin-containing compound metabolic process.] |
| AApoAI amyloidosis | MONDO_0019731 | |
| AFib amyloidosis | MONDO_0019733 | |
| ALys amyloidosis | MONDO_0019732 | |
| ceftriaxone | CHEBI_29007 | [A cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side groups.] |
| hyperkeratosis-hyperpigmentation syndrome | MONDO_0007757 | [Hyperkeratosis-hyperpigmentation syndrome describes a very rare hyperpigmentation of the skin characterized by tiny hyperpigmented spots mainly on skin exposed to sunlight, together with mild punctate palmoplantar papular hyperkeratosis as a major feature. There have been no further descriptions in the literature since 1993.] |
| epidermolytic palmoplantar keratoderma | MONDO_0007758 | [A genetic skin disorder caused by mutations in the KRT9 gene. It is characterized by hyperkeratosis in the palms and soles resulting in abnormal thickening of the skin in these areas.] |
| hyperkeratosis lenticularis perstans | MONDO_0007756 | |
| hypercholesterolemia, autosomal dominant, type B | MONDO_0007751 | |
| hypercholesterolemia, familial, 1 | MONDO_0007750 | |
| cystinuria type B | MONDO_0019746 | |
| cystinuria type A | MONDO_0019745 | |
| cefalotin | CHEBI_124991 | |
| late-onset nephronophthisis | MONDO_0019742 | |
| familial cystic renal disease | MONDO_0019741 | [An instance of cystic kidney disease that is caused by an inherited modification of the individual's genome.] |
| Cystic Kidney Disease | EFO_0008615 | [A congenital or acquired kidney disorder characterized by the presence of renal cysts. [ NCI ], A congenital or acquired kidney disorder characterized by the presence of renal cysts.] |
| 3-phosphoglyceric acid | CHEBI_17050 | [A monophosphoglyceric acid having the phospho group at the 3-position. It is an intermediate in metabolic pathways like glycolysis and calvin cycle.] |